The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease

Transl Vis Sci Technol. 2021 Jul 1;10(8):4. doi: 10.1167/tvst.10.8.4.

Authors

Affiliations

¹ Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
² Stanford Cardiovascular Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
³ Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, OH, USA.
⁴ Department of Pediatrics, Division of Medical Genetics, Stanford University School of Medicine, Palo Alto, CA, USA.

Abstract

Mitochondria are viable therapeutic targets for a broad spectrum of ocular diseases.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Eye Diseases* / drug therapy
Humans
Mitochondria*

Grants and funding

P30 EY026877/EY/NEI NIH HHS/United States